Results 331 to 339 of about 77,471 (339)

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab†

Annals of Oncology, 2016
Emilio Bria, C Schem, E Holmes
exaly  

PIK3CA mutation status in Japanese lung cancer patients

Lung Cancer, 2006
Katsuhiko Endo, Haruhiro Yukiue, Hiroshi Haneda   +2 more
exaly  

Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing

Genetics in Medicine, 2017
Jeanne Amiel, Isidor B, David Geneviève
exaly  

PIK3CA and Breast Cancer

Advances in Molecular Pathology, 2020
openaire   +1 more source

Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum

American Journal of Medical Genetics, Part A, 2017
Godfrey Chi Fung Chan, Kit San Yeung, Paul Kwong Hang Tam   +2 more
exaly  

People also looked at

Frontiers in Oncology, 2014
Gieri Cathomas
exaly  

Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer†

Journal of Pathology, 2009
Ghazi Alsbeih, Rong Bu, Prashant Bavi
exaly  

PIK3CA NP_006209.2:p.E545V

2020
openaire   +1 more source

Polynucleotide primers for detecting pik3ca mutations

2009
BOARD RUTH, FERGUSON JENNIFER, RAVETTO PAUL FRANCIS, THELWELL NICOLA JO, WHITCOMBE DAVID   +4 more
openaire   +15 more sources